The precision neurology market is growing rapidly due to increasing demand for personalized neurological treatments, advancements in genomic medicine, and the rising prevalence of neurodegenerative disorders worldwide. AI-powered diagnostics and biomarker-based therapies are further transforming the market landscape.
What is the Precision Neurology Market Size in 2026?
The global precision neurology market size was calculated at USD 18.40 billion in 2025 and is predicted to increase from USD 21.07 billion in 2026 to approximately USD 70.63 billion by 2035, expanding at a CAGR of 14.60% from 2026 to 2035. The increasing prevalence of neurological disorders and advances in precision healthcare research are key drivers of market growth.
Market Highlights
- North America led the market with a share of 41% in 2025.
- Asia-Pacific is expected to be the fastest-growing region with a CAGR of 19.8% in the forecasted duration.
- By technology, the genomics segment led the precision neurology market with 28% share in 2025.
- By technology, the AI and machine learning analytics segment is expected to grow at the fastest CAGR of 24.5% in the predictive window.
- By therapeutic area, the Alzheimers disease segment led the global market with a share of 30% in 2025 and is expected to be the fastest-growing segment with a CAGR of 17% in the fiscal period.
- By application, the personalized diagnostics segment led the global market with a share of 26% in 2025.
- By application, the precision therapeutics segment is expected to grow at the highest CAGR of 18.5% in the foreseeable period.
- By end-use, the hospitals segment led the global market with a share of 36% in 2025.
- By end-use, the pharmaceutical and biotechnology companies segment is expected to witness the fastest growth with a CAGR of 18.8% in the fiscal period.
Market Overview
The precision neurology market is witnessing substantial growth as healthcare providers and biotechnology companies focus on individualized treatment approaches for neurological disorders. Precision neurology combines genomics, biomarkers, advanced imaging, and data analytics to deliver targeted therapies based on patient-specific characteristics.
The increasing prevalence of neurological diseases such as Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, and rare genetic disorders is driving demand for precision medicine solutions. Rising investments in neuroscience research, technological advancements in molecular diagnostics, and expanding adoption of personalized healthcare are further contributing to market growth.
Additionally, pharmaceutical companies are increasingly developing targeted neurological therapies and companion diagnostics to improve treatment outcomes and reduce adverse effects.
Market Trends
The precision neurology market is evolving through several emerging trends that are reshaping neurological healthcare. One major trend is the growing integration of genomics and biomarker testing into routine neurological diagnosis and treatment planning.
Another significant trend is the increasing use of advanced neuroimaging technologies and digital health platforms for real-time disease monitoring and patient management. Pharmaceutical and biotechnology companies are also focusing on precision therapeutics and gene-based treatment strategies for complex neurological conditions.
Collaborations between healthcare organizations, research institutes, and AI technology providers are accelerating innovation in predictive analytics and precision diagnostics. The expansion of clinical trials focused on targeted neurological therapies is also supporting long-term market development.
AI Impact on the Precision Neurology Market
Artificial intelligence is playing a transformative role in the precision neurology market by enabling faster diagnosis, predictive disease modeling, and personalized treatment planning. AI-powered algorithms can analyze neurological imaging data, genetic information, and patient histories to identify disease patterns with improved accuracy.
Machine learning and deep learning technologies are helping researchers discover novel therapeutic targets and optimize clinical trial processes. AI is also improving early detection of neurological disorders, supporting better patient outcomes and disease management.
Additionally, AI-driven precision medicine platforms are enhancing treatment recommendations by identifying individualized therapeutic responses based on genetic and biomarker profiles. The increasing integration of AI into neurology research and healthcare systems is expected to create significant growth opportunities in the market.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 18.40 Billion |
| Market Size in 2026 | USD 21.07 Billion |
| Market Size by 2035 | USD 70.63 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 14.60% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Technology, Therapeutic Area, Application, End-use, Delivery Model, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Segment Insights
By Disease Type
Neurodegenerative diseases account for a major share of the precision neurology market due to the increasing burden of Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. Genetic neurological disorders and epilepsy are also contributing significantly to market demand.
By Technology
Genomic sequencing, biomarker analysis, advanced neuroimaging, and AI-driven diagnostics are among the leading technologies driving precision neurology adoption. Molecular diagnostics and companion diagnostic tools are gaining strong traction globally.
By Treatment Type
Targeted therapies, gene therapies, biologics, and precision pharmaceuticals are emerging as key treatment segments. Personalized treatment strategies are increasingly improving therapeutic effectiveness and patient outcomes.
By End User
Hospitals, specialty neurology clinics, research institutes, and pharmaceutical companies represent major end users in the precision neurology market. Academic research centers are also playing a critical role in advancing neuroscience innovation.
Regional Insights
North America dominates the precision neurology market due to advanced healthcare infrastructure, strong biotechnology presence, and high investments in neuroscience research. The region benefits from rapid adoption of AI-powered healthcare technologies and precision medicine initiatives.
Europe is witnessing steady growth driven by increasing awareness regarding personalized medicine and strong government support for neurological research programs. Expanding clinical trial activities and biotechnology collaborations are supporting regional market expansion.
Asia Pacific is expected to experience rapid growth due to improving healthcare infrastructure, rising neurological disease prevalence, and growing investments in precision medicine technologies. Increasing healthcare digitization and expanding biotechnology sectors are accelerating market growth.
These regions are gradually emerging in the precision neurology market due to improving access to healthcare technologies, rising awareness about neurological disorders, and increasing investments in medical research and diagnostics.
Precision Neurology Market Key Players
- F. Hoffmann-La Roche Ltd.
- Biogen Inc.
- Novartis AG
- Pfizer Inc.
- Eli Lilly and Company
- AbbVie Inc.
- Thermo Fisher Scientific
- Illumina Inc
- Qiagen N.V.
- Siemens Healthineers
- GE HealthCare
- Quanterix Corporation
- Bio-Rad Laboratories
- AC Immune SA
- Alector Inc.
Recent Developments
- In April 2026, Cedars-Sinai Guerin Children’s launched the first Neuro Neonatal Intensive Care Unit in the Los Angeles region, bringing specialized neurological care to newborns during a critical stage of early brain development.
- In March 2026, Alamar Biosciences launched the NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel, offering the sensitivity and specificity needed to advance neurological disease research.
Segments Covered in the Report
By Technology
- Genomics
- Whole Genome Sequencing
- Targeted Gene Panels
- Pharmacogenomics
- Proteomics
- Biomarker-based Diagnostics
- AI & Machine Learning Analytics
- Neuroimaging Technologies
- MRI
- PET
- Functional Neuroimaging
By Therapeutic Area
- Alzheimer’s Disease
- Parkinson’s Disease
- Multiple Sclerosis
- Epilepsy
- Amyotrophic Lateral Sclerosis (ALS)
- Autism Spectrum Disorders
- Stroke
- Other Neurological Disorders
By Application
- Personalized Diagnostics
- Precision Therapeutics
- Drug Discovery & Development
- Disease Risk Prediction
- Patient Stratification
- Monitoring & Prognostics
By End-use
- Hospitals
- Specialty Neurology Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
By Delivery Model
- Hospital-based Precision Neurology
- Cloud-based Neurology Platforms
- AI-assisted Neurology Solutions
By Region
- North America
- Latin America
- Europe
- Asia-pacific
- Middle and East Africa
Get Sample Link : https://www.precedenceresearch.com/sample/8434
Also Read Our Latest Article : Neuroinflammation Market